Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
January 20 2021
February 3-5th 2021 : Defymed is very happy to announce its participation in the EAHAD (European Ass...
January 12 2021
Defymed ISO 13485 :2016 Communication TuvSud Defymed is proud to announce the certification transfer...